조사용 항체 및 시약 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 기술별, 용도별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)
Research Antibodies and Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1886510
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 조사용 항체 및 시약 시장은 2024년에 106억 9,000만 달러로 평가되며, 2030년까지 CAGR 5.96%로 성장하며, 151억 3,000만 달러에 달할 것으로 예측됩니다. 연구용 항체는 표적 분자에 특이적으로 결합하도록 설계되었거나 천연 유래 단백질입니다. 한편, 시약은 단백질체학, 유전체학, 신약 개발 등의 응용 분야에서 생체 분자의 검출, 정량 및 분리에 필수적인 툴로 작용하는 다양한 실험실 분석에 필수적인 기타 중요한 화학 물질 및 생물학적 물질을 포함합니다. 시장 성장은 주로 생명과학 연구에 대한 세계 투자 증가, 광범위한 생물의학 연구가 필요한 만성질환의 확산, 그리고 산학협력의 활성화에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
106억 9,000만 달러
시장 규모 : 2030년
151억 3,000만 달러
CAGR : 2025-2030년
5.96%
가장 빠르게 성장하는 부문
항체
최대 시장
북미
주요 시장 성장 촉진요인
세계 연구용 항체 및 시약 시장은 생명과학 분야의 R&D 투자 증가와 유전체학 및 단백질체학 연구의 발전으로 인해 크게 성장하고 있습니다. 정부 기관과 제약회사의 탄탄한 자금 지원은 이러한 성장의 대부분을 지원하고 있으며, 전문 연구 툴에 대한 수요를 촉진하고 있습니다.
주요 시장 과제
항체의 품질과 배치 간 재현성에 대한 지속적인 우려는 세계 연구용 항체 및 시약 시장의 성장에 큰 걸림돌이 되고 있습니다. 이 문제는 연구자들이 실험 결과를 손상시키는 제품 성능의 편차에 자주 직면하므로 과학 연구의 신뢰성을 직접적으로 손상시키는 문제입니다.
주요 시장 동향
재조합 항체 및 디자인 항체의 개발이 진행되면서 기존 항체 포맷에 비해 특이성, 재현성, 범용성이 향상됨에 따라 전 세계 연구용 항체 및 시약 시장에 큰 영향을 미치고 있습니다. 이러한 첨단 항체는 로트 간 편차를 최소화하고 복잡한 생물학적 시스템에서 보다 정밀한 표적화를 가능하게 합니다. 이는 첨단 연구 분야에서 매우 중요합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 조사용 항체 및 시약 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
제품별(항체, 시약)
기술별(웨스턴 블롯, 유세포분석, ELISA)
용도별(단백질체학, 유전체학)
최종사용자별(제약, 바이오테크놀러지, CRO)
지역별
기업별(2024)
시장 맵
제6장 북미의 조사용 항체 및 시약 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 조사용 항체 및 시약 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 조사용 항체 및 시약 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 조사용 항체 및 시약 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 조사용 항체 및 시약 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 조사용 항체 및 시약 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Abcam Plc.
Thermo Fischer Scientific, Inc.
Merck KGaA
F. Hoffmann-La Roche Ltd.
Bio-Rad laboratories, Inc.
Agilent Technologies, Inc.
Danaher corporation
Lonza Group Ltd.
Genscript Biotech Corporation
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Research Antibodies and Reagents Market, valued at USD 10.69 Billion in 2024, is projected to experience a CAGR of 5.96% to reach USD 15.13 Billion by 2030. Research antibodies are proteins engineered or naturally derived to specifically bind target molecules, while reagents encompass other critical chemical and biological substances integral to diverse laboratory assays, serving as indispensable tools for detecting, quantifying, and isolating biomolecules in applications such as proteomics, genomics, and drug discovery. The market's growth is primarily driven by increasing global investment in life science research, the expanding prevalence of chronic diseases necessitating extensive biomedical investigation, and robust industry-academia collaborations.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 10.69 Billion
Market Size 2030
USD 15.13 Billion
CAGR 2025-2030
5.96%
Fastest Growing Segment
Antibodies
Largest Market
North America
Key Market Drivers
The global research antibodies and reagents market is significantly propelled by increasing life sciences research and development investments and advancements in genomics and proteomics research. Robust funding commitments from governmental bodies and pharmaceutical companies underpin a substantial portion of this growth, fueling the demand for specialized research tools.
Key Market Challenges
The persistent concern regarding antibody quality and batch-to-batch reproducibility represents a significant impediment to the growth of the Global Research Antibodies and Reagents Market. This challenge directly undermines the reliability of scientific investigations, as researchers frequently encounter variations in product performance that compromise experimental outcomes. Consequently, a considerable portion of research time and resources is diverted to extensive, often redundant, validation processes for reagents before reliable results can be obtained. This ongoing need for in-house validation diminishes efficiency and increases operational costs for research laboratories.
Key Market Trends
The growing development of recombinant and engineered antibodies significantly influences the global research antibodies and reagents market by offering enhanced specificity, reproducibility, and versatility compared to traditional antibody formats. These advanced antibodies minimize batch-to-batch variation and enable more precise targeting in complex biological systems, which is crucial for sophisticated research applications.
Key Market Players
Abcam Plc.
Thermo Fischer Scientific, Inc.
Merck KGaA
F. Hoffmann-La Roche Ltd.
Bio-Rad laboratories, Inc.
Agilent Technologies, Inc.
Danaher corporation
Lonza Group Ltd.
Genscript Biotech Corporation
Report Scope:
In this report, the Global Research Antibodies and Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Research Antibodies and Reagents Market, By Product:
Antibodies
Reagents
Research Antibodies and Reagents Market, By Technology:
Western Blot
Flow Cytometry
ELISA
Research Antibodies and Reagents Market, By Application:
Proteomics
Genomics
Research Antibodies and Reagents Market, By End User:
Pharma
Biotech
CRO
Research Antibodies and Reagents Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Research Antibodies and Reagents Market.
Available Customizations:
Global Research Antibodies and Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Research Antibodies and Reagents Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Antibodies, Reagents)
5.2.2. By Technology (Western Blot, Flow Cytometry, ELISA)
5.2.3. By Application (Proteomics, Genomics)
5.2.4. By End User (Pharma, Biotech, CRO)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Research Antibodies and Reagents Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Research Antibodies and Reagents Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Research Antibodies and Reagents Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Research Antibodies and Reagents Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Research Antibodies and Reagents Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Research Antibodies and Reagents Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. France Research Antibodies and Reagents Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Research Antibodies and Reagents Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Research Antibodies and Reagents Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Research Antibodies and Reagents Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia Pacific Research Antibodies and Reagents Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Research Antibodies and Reagents Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Research Antibodies and Reagents Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Research Antibodies and Reagents Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Research Antibodies and Reagents Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Research Antibodies and Reagents Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. Middle East & Africa Research Antibodies and Reagents Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Research Antibodies and Reagents Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. UAE Research Antibodies and Reagents Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. South Africa Research Antibodies and Reagents Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. South America Research Antibodies and Reagents Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Research Antibodies and Reagents Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Colombia Research Antibodies and Reagents Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Argentina Research Antibodies and Reagents Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Research Antibodies and Reagents Market: SWOT Analysis
